FDA Inspection
BASF CorporationBASF Corporation – FDA Inspection, May 29, 2025
Record Details
This FDA Inspection record concerns BASF Corporation, with an inspection on May 29, 2025, issued by the New York District Office, covering human drugs.
- Office
- New York District Office
- Person
View Company Profile
ID · 80c55f36-efeb-402b-9d1f-4ddf88c72dca
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1271052
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BASF Corporation
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BASF Corporation
- FDA Inspection 1031534 - 2017-11-17
- FDA Inspection 629448 - 2009-11-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.